A 48-year-old male with allergic bronchopulmonary aspergillosis: a rare case report

Allergic bronchopulmonary mycoses, primarily from Aspergillus fumigatus, complicate asthma and cystic fibrosis, presenting diagnostic challenges due to overlapping respiratory symptoms.

A 48-year-old male with asthma and a history of Guillain-Barré syndrome presented with cough, chest pain, dyspnea, and weight loss. He was diagnosed with allergic bronchopulmonary aspergillosis after a series of investigations, including CT scans and bronchoscopy.

Allergic bronchopulmonary aspergillosis (ABPA) is a rare lung disease caused by an immune reaction to Aspergillus fungi in individuals with pre-existing respiratory conditions like asthma or cystic fibrosis. The primary treatment for ABPA involves systemic corticosteroids, often combined with antifungal agents, to reduce the need for long-term high-dose steroid therapy.

This case highlights the need for accurate and early diagnosis of ABPA, especially in patients with asthma or other respiratory diseases, which helps prevent potential complications. Additionally, the case provides valuable insights into how to manage patients with ABPA, contributing to the improvement of protocols and medical care in the future.